US Stock MarketDetailed Quotes
ABIO ARCA biopharma
- 3.290
- +0.070+2.17%
Close May 7 16:00 ET
- 3.350
- +0.060+1.82%
Post 19:51 ET
47.73MMarket Cap-7833P/E (TTM)
3.350High3.210Low33.62KVolume3.220Open3.220Pre Close110.12KTurnover0.68%Turnover RatioLossP/E (Static)14.51MShares3.88052wk High1.36P/B16.21MFloat Cap1.56052wk Low--Dividend TTM4.93MShs Float6327683.189Historical High--Div YieldTTM4.35%Amplitude1.560Historical Low3.275Avg Price1Lot Size
About ARCA biopharma Company
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
Company Profile
SymbolABIO
Company NameARCA biopharma
Listing DateAug 8, 1997
Issue Price14.00
Founded1992
CEOMr. Thomas A. Keuer
MarketNASDAQ
Employees5
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10170 Church Ranch Way,Suite 100
CityWestminster
ProvinceColorado
CountryUnited States of America
Zip Code80021
Phone1-720-940-2100
Websitehttp://www.arcabio.com
Company Executives
- Name
- Position
- Salary
- C. Jeffrey Dekker
- Secretary, Chief Financial Officer, Principal Accounting Officer and Treasurer
- --
- Thomas A. Keuer
- Chief Operating Officer, President and Principal Executive Officer
- 448.99K
- Robert E. Conway
- Chairman of the Board
- 101.34K
- Jacob Ma-Weaver
- Director
- 53.89K
- Dr. Linda S. Grais, J.D.,M.D.
- Independent Director
- 68.84K
- James Flynn
- Independent Director
- 24.68K
- Dr. Anders D. Hove,M.D.
- Independent Director
- 56.34K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg